Skip to main content

Month: March 2020

Prospekt – Investeringsforeningen Stonehenge

Copenhagen, March 18, 2020 (GLOBE NEWSWIRE) —Opdateret prospekt for Investeringsforeningen Stonehenge offentliggøres dags dato.Dokumentet kan downloades fra www.stonehenge.dk eller rekvireres ved henvendelse til BI Management A/S, Sundkrogsgade 7, 2100 København Ø, tlf. 77 30 90 00.Prospektet er opdateret med ændret investeringspolitik samt korrekturrettelser mv.Med venlig hilsenBI Management A/SMalene EhrenskjöldDirektørVedhæftede filerProspekt Stonehenge 2020.03.18 CleanVedtægter Stonehenge 2019.08.28 clean

Continue reading

Sportsman’s Warehouse Holdings, Inc. Announces Fourth Quarter and Fiscal Year 2019 Earnings Conference Call

WEST JORDAN, Utah, March 18, 2020 (GLOBE NEWSWIRE) — Sportsman’s Warehouse Holdings, Inc. (“Sportsman’s Warehouse” or the “Company”) (Nasdaq: SPWH) today announced that it will hold its quarterly conference call to discuss fourth quarter and fiscal year 2019 financial results on Thursday, March 26, 2020 at 4:30 p.m. Eastern Time.The conference call will be broadcast on the Company’s investor relations website at http://investors.sportsmans.com/. An online archive of the webcast will be available for one year following the call.About Sportsman’s Warehouse Holdings, Inc.Sportsman’s Warehouse is an outdoor sporting goods retailer focused on meeting the everyday needs of the seasoned outdoor veteran, the first-time participant and everyone in between. We provide outstanding gear and exceptional...

Continue reading

eQ PLC’S ANNUAL GENERAL MEETING 2020 – Precautionary measures due to the coronavirus

eQ PLC INVESTOR NEWS18 March 2020, at 2:40 p.m.eQ Plc published a notice of the Annual General Meeting on 6 February 2020 (“AGM”). The said stock exchange release can be found here: https://tools.euroland.com/tools/Pressreleases/GetPressRelease/?ID=3696366&lang=en-GB&companycode=sf-ama&v=sf-ama_neweQ Plc has decided to initiate a series of precautionary measures for the AGM to be held on Wednesday 25 March 2020 at 16.00 EET at Rake-Sali Ball Room, at Bulevardi 2, Helsinki in order to decrease the risk of spread of coronavirus.eQ Plc’s shareholders can follow the AGM through a live webcast stream, and present questions before and during the AGM. A link to the live webcast stream and other AGM materials can be found here: https://www.eq.fi/en/about-eq-group/hallinnointi/yhtiokokoukset. It is not possible for a shareholder...

Continue reading

eQ OYJ YHTIÖKOKOUS 2020 – Koronaviruksen vuoksi muuttuneet järjestelyt

eQ OYJ SIJOITTAJAUUTINEN18.3.2020, klo 14:40Kutsu eQ Oyj:n yhtiökokoukseen julkaistiin pörssitiedotteella 6.2.2020. Kyseinen tiedote löytyy alla olevan linkin takaa: https://tools.euroland.com/tools/Pressreleases/GetPressRelease/?ID=3696367&lang=fi-FI&companycode=sf-ama&v=sf-ama_new.eQ Oyj on päättänyt useista, 25.3.2020 klo 16.00 Rake-salissa järjestettävään varsinaiseen yhtiökokoukseen liittyvistä ennaltaehkäisevistä toimista pienentääkseen riskiä koronaviruksen leviämisestä.  eQ Oyj:n yhtiökokouksesta järjestetään webcast-lähetys, jonka kautta osakkeenomistajilla on mahdollisuus seurata yhtiökokousta videoyhteydellä. Webcast-palvelun kautta osakkeenomistaja voi lähettää kysymyksiä etukäteen sekä kokouksen kuluessa. Linkki webcast-lähetyksen seurantasivulle ja muihin yhtiökokous-materiaaleihin löytyy yhtiön verkkosivuilta:...

Continue reading

Kapitalforeningen Jyske Portefølje ophæver suspension af handel med afdeling FX Alpha II

Der offentliggøres igen indre værdi for afdeling FX Alpha II i Kapitalforeningen Jyske Portefølje og suspensionen af handel med afdelingen ophæves hermed.Dermed kan der igen handles i afdeling FX Alpha II.Øvrig informationHenvendelser vedrørende denne meddelelse kan ske til Senior Director Finn Beck,tlf. 89 89 25 00.Venlig hilsenFinn Beck        Senior DirectorVedhæftet fil18 – 2020 03 18 Ophævelse af suspension

Continue reading

EHang Partners with Llíria of Spain to Expand UAM Pilot City Initiative in Europe

GUANGZHOU, China, March 18, 2020 (GLOBE NEWSWIRE) — EHang Holdings Limited (“EHang” or the “Company”) (Nasdaq: EH), the world’s leading autonomous aerial vehicle (“AAV”) technology platform company, today announced that it established a strategic partnership with Llíria in Spain as its fourth urban air mobility (“UAM”) pilot city globally following Seville in Spain, Linz in Austria and Guangzhou in China.As a technology pioneer and the first to market in the UAM industry, EHang will collaborate with the Llíria City Council to develop a 3D air mobility solution for smart cities and launch a pilot operation program of passenger-grade AAVs designed to explore different application scenarios including tourism. In addition, EHang and Llíria City Council will work together with the Spanish Aviation Safety and Security Agency to...

Continue reading

Investeringsforeningen Jyske Invest ophæver suspension af handel for udvalgte afdelinger

Der offentliggøres igen indre værdier for udvalgte afdelinger i Investeringsforeningen Jyske Invest og suspensionen af handel ophæves hermed i følgende afdelinger:Dermed kan der igen handles i investeringsforeningens børsnoterede afdelinger, bortset fra nedenstående, der fortsat er suspenderede jf. selskabsmeddelelse nr. 29/2020 af 18.03.2020:Øvrig informationHenvendelser vedrørende denne meddelelse kan ske til Senior Director Finn Beck,tlf. 89 89 25 00.Venlig hilsenFinn Beck        Senior DirectorVedhæftet fil30 – 2020 03 18 Ophævelse af suspension

Continue reading

Synairgen to start trial of SNG001 in COVID-19 imminently

Press releaseSynairgen plc(‘Synairgen’ or the ‘Company’)Synairgen to start trial of SNG001 in COVID-19 imminentlySouthampton, UK – 18 March 2020: Synairgen plc (LSE: SNG), the respiratory drug discovery and development company, today announces that it has received expedited approvals from the Medicines and Healthcare products Regulatory Agency (MHRA) and Health Research Authority (HRA) to conduct a trial of SNG001 (inhaled formulation of interferon-beta-1a) in COVID-19 patients to potentially assist with the global outbreak of the virus.   COVID-19COVID-19, caused by the SARS-CoV-2 virus, is a global threat and there is an urgent need to assess new treatments to prevent and effectively treat the severe lower respiratory tract illness that can occur with this disease. Older people and those with co-morbidities such as heart and lung complications...

Continue reading

BioSyent Releases Results for Fourth Quarter and Full Year 2019

MISSISSAUGA, Ontario, March 18, 2020 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today a summary of its financial results for the three and twelve months ended December 31, 2019.  Key highlights include:Fourth quarter (Q4) 2019 Net Revenues of $5,569,286 decreased by 6% versus Q4 2018Full year (FY) 2019 Net Revenues of $21,424,324 flat versus FY 2018Q4 2019 Canadian Pharmaceutical Net Revenues of $5,042,899 flat versus Q4 2018FY 2019 Canadian Pharmaceutical Net Revenues of $18,946,758 increased by 2% versus FY 2018Q4 2019 International Pharmaceutical Net Revenues of $428,620 decreased by 50% versus Q4 2018FY 2019 International Pharmaceutical Net Revenues of $1,441,691 decreased by 35% versus FY 2018Q4 2019 net write-downs on intangible assets of $446,006FY 2019 net write-downs on intangible assets of...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.